U.S. Markets closed

Cyren Reports Fourth Quarter and Full Year 2018 Financial Results

Full year 2018 revenue grew 17% while fourth quarter revenue was up 26% year-over-year

MCLEAN, Va., Feb. 13, 2019 /PRNewswire/ -- Cyren (CYRN) today announced its fourth quarter and full year 2018 financial results for the period ending December 31, 2018.  

During the fourth quarter, Cyren reported quarterly revenues of $9.5 million – an increase of 26% over the fourth quarter of 2017.  For the full year ending 2018, Cyren reported revenues of $35.9 million, up 17% over the full year 2017, and representing the highest annual revenue total the company has ever recorded.

"We are pleased with our fourth quarter performance that tops off a record breaking year for Cyren," said Lior Samuelson, Chairman and CEO of Cyren. "During the quarter, we brought a number of new enterprise customers onto the Cyren Cloud Security platform, and renewed contracts with two of our largest customers using our Threat Intelligence Services.  Throughout 2018, we had a number of significant achievements including signing our largest CCS enterprise customer, with over 100,000 active email accounts, and the largest contract in our company's history.  We plan on launching some exciting new enterprise products over the coming two quarters, and are looking forward to continued progress in 2019."

Cyren previously discussed that it plans to launch two significant products during 2019.  The company is developing a next generation enterprise class anti-phishing solution which is intended to allow enterprises to proactively remediate and remove phishing emails after they have been delivered to a user's mailbox, regardless of who the company is using as an email gateway for their primary level of protection.  Cyren also announced a collaboration with Microsoft to integrate Cyren web security technology directly into the Windows Defender Advanced Threat Protection platform in order to provide an additional layer of protection to Windows Defender enterprise customers.  Both products are anticipated to be generally available later in 2019.

Fourth Quarter 2018 Financial Highlights:

  • Revenues for the fourth quarter of 2018 were $9.5 million, compared to $7.5 million for the fourth quarter of 2017.
  • Revenues for the year ended December 31, 2018 were $35.9 million compared to $30.8 million for fiscal year 2017.
  • GAAP net loss for the fourth quarter of 2018 was $5.6 million, compared to a net loss of $7.2 million in the fourth quarter of 2017.
  • GAAP net loss for the year ended December 31, 2018 was $19.4 million, compared to $15.6 million for 2017.
  • GAAP loss per basic and diluted share for the fourth quarter of 2018 was $0.10, compared to a loss of $0.16 for the fourth quarter of 2017. For the full year 2018, GAAP loss per basic and diluted share was $0.36, compared to a loss of $0.38 for full year 2017.                                                                                                                  
  • Non-GAAP net loss for the fourth quarter of 2018 was $4.4 million, compared to a Non-GAAP net loss of $4.3 million for the fourth quarter of 2017.
  • Non-GAAP net loss for the full year 2018 was $16.1 million, compared to a Non-GAAP net loss of $12.4 million for the year ended 2017.
  • Non-GAAP loss per basic and diluted share was $0.07 for the fourth quarter of 2018, compared to a Non-GAAP loss of $0.09 in fourth quarter of 2017. Non-GAAP loss per basic and diluted share was $0.29 for full year 2018, compared to $0.29 during full year 2017.
  • Cash balance as of December 31, 2018 was $17.6 million, compared to $24.0 million as of December 31, 2017. The cash balance at year end includes net proceeds of $10 million from 3-year convertible notes which were issued in November.

For information regarding the non-GAAP financial measures discussed in this release, please see "Use of Non-GAAP Financial Measures" and "Reconciliation of Selected GAAP Measures to Non-GAAP Measures."

Recent Business Highlights:

  • During the fourth quarter, Cyren expanded service to its largest enterprise customer – an international company who selected Cyren's CCS platform for email security and cloud sandboxing.  The multi-year, multi-million dollar contract which was previously announced with 80,000 enterprise users, has grown to over 100,000 active enterprise users on the Cyren network.
  • Also in the fourth quarter, Cyren renewed and expanded two of the company's top 5 revenue customers using Cyren's Threat Intelligence Services.  One of the contracts was renewed at a 17% premium, and includes a significant multi-year prepayment, which will have a positive impact on operating cash flow during the first quarter of 2019.
  • Cyren recently announced a partnership with Microsoft to integrate its web security technology directly into Windows Defender Advanced Threat Protection (ATP).  The new integrated offering will initially be made available as a private preview with a select set of enterprise customers expected during the first half of 2019, with the goal of reaching general availability for all Windows Defender ATP customers later in the year.
  • In January, Cyren announced that it will be voluntarily delisting from the Tel Aviv Stock Exchange (TASE).  Cyren will continue to maintain its headquarters in Herzliya, Israel and operate as an Israeli-registered company, but the move is an effort to simplify regulatory filings and concentrate fragmented trading volume onto the Nasdaq exchange.  The delisting is expected to become effective in April.

Financial Results Conference Call:

The company will also host a conference call at 10 a.m. Eastern Time (5 p.m. Israel Time) on Wednesday, February 13, 2019.

US:

1-877-407-0312

Israel:

1-80-940-6247

International:

1-201-389-0899

The call will be simultaneously webcast live on the investor relations section of Cyren's website at http://ir.cyren.com, or by using the following link: https://webcasts.eqs.com/cyren20190213.

For those unable to participate in the live conference call, a replay will be available until February 27, 2019. To access the replay, the U.S. dial in number is 1-877-660-6853 and the non-U.S. dial in number is 1-201-612-7415. Callers will be prompted for replay conference ID number 13686826. An archived version of the webcast will also be available on the investor relations section of the company's website at http://ir.cyren.com/events.

About Cyren
More than 1.3 billion users around the world rely on Cyren's 100% cloud internet security solutions to protect them against cyber attacks and data loss every day. Powered by the world's largest security cloud, Cyren (CYRN) delivers fast time to protection from cyber threats with award-winning security as a service for web, email, sandboxing, and DNS for enterprises, and embedded threat intelligence solutions for security vendors and service providers. Customers like Google, Microsoft and Check Point are just a few of the businesses that depend on Cyren every day to power their security. Learn more at www.cyren.com.

Blog: blog.cyren.com
Facebook: www.facebook.com/CyrenWeb
LinkedIn: www.linkedin.com/company/cyren
Twitter: www.twitter.com/CyrenInc

Use of Non-GAAP Financial Measures:

Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: stock-based compensation expenses, amortization of acquired intangible assets and deferred taxes related to acquisitions, one-time gain from sale of investment in affiliate, adjustments to earn-out obligations, capitalization of technology, accretion of discount on convertible note and change in fair value of the embedded conversion feature. The purpose of such adjustments is to give an indication of the company's performance exclusive of non-cash charges and other items that are considered by management to be outside of the company's core operating results. The company's non-GAAP financial measures are not meant to be considered in isolation or as a substitute for comparable GAAP measures, and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Company management regularly uses supplemental non-GAAP financial measures internally to understand, manage and evaluate the business and make operating decisions.

These non-GAAP measures are among the primary factors management uses in planning for and forecasting future periods. The company believes this adjustment is useful to investors as a measure of the ongoing performance of the business. The company believes these non-GAAP financial measures provide consistent and comparable measures to help investors understand the company's current and future operating cash flow performance. These non-GAAP financial measures may differ materially from the non-GAAP financial measures used by other companies. Reconciliation between results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statements of Income. The presentation of this non-GAAP financial information is not intended to be considered in isolation or as a substitute for the financial information prepared and presented in accordance with GAAP. Management uses both GAAP and non-GAAP measures when evaluating the business internally and therefore felt it important to make these non-GAAP adjustments available to investors.

This press release contains forward-looking statements, including projections about the company's business, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. For example, statements in the future tense, and statements including words such as "expect," "plan," "estimate," "anticipate," or "believe" are forward-looking statements. These statements are based on information available at the time of the press release and the company assumes no obligation to update any of them. The statements in this press release are not guarantees of future performance and actual results could differ materially from current expectations as a result of numerous factors, including business conditions and growth or deterioration in the internet security market, technological developments, products offered by competitors, availability of qualified staff, and technological difficulties and resource constraints encountered in developing new products, as well as those risks described in the company's Annual Reports and current reports on Form 8-K, which are available through www.sec.gov.

Company Contact
Mike Myshrall, CFO
Cyren
+1.703.760.3320
mike.myshrall@cyren.com

Media Contact
Matthew Zintel
Zintel Public Relations
+1.281.444.1590
matthew.zintel@zintelpr.com 

CYREN LTD.









 CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS









(in thousands of U.S. dollars, except per share amounts)


































Three months ended 


Twelve months ended 

December 31


December 31


2018


2017


2018


2017


Unaudited


Unaudited


Unaudited


Audited









 Revenues 

$    9,512


$    7,522


$   35,900


$   30,799









 Cost of revenues 

3,856


3,177


14,540


11,899









Gross profit 

5,656


4,345


21,360


18,900

















Operating expenses:
















 Research and development, net

4,761


2,896


16,116


9,825









 Sales and marketing 

4,069


4,156


16,202


15,551









 General and administrative 

2,192


2,313


8,343


7,286









 Total operating expenses 

11,022


9,365


40,661


32,662









Operating loss

(5,366)


(5,020)


(19,301)


(13,762)









Other income (expense), net

6


1


(11)


452









Financial expense, net 

(164)


(2,117)


(255)


(2,380)









Loss before taxes

(5,524)


(7,136)


(19,567)


(15,690)









Tax benefit

(48)


(106)


153


42

















Net loss

$   (5,572)


$   (7,242)


$ (19,414)


$ (15,648)

















Loss per share - basic

$     (0.10)


$     (0.16)


$      (0.36)


$      (0.38)









Loss per share - diluted 

$     (0.10)


$     (0.16)


$      (0.36)


$      (0.38)









Weighted average number of shares outstanding: 








Basic 

54,023


46,018


53,634


40,922









Diluted  

54,023


46,018


53,634


40,922

 


CYREN LTD.





CONDENSED CONSOLIDATED BALANCE SHEETS





(in thousands of U.S. dollars)










December 31


December 31


2018


2017


Unaudited


Audited





                 Assets




    Current Assets:




Cash and cash equivalents 

$         17,571


$         23,981

Trade receivables, net

3,658


2,890

Deferred commissions

887


-

Prepaid expenses and other receivables

778


1,339

 Total current assets 

22,894


28,210





Long-term deferred commissions

1,880


-

Lease deposits 

821


379

Severance pay fund 

503


714

Property and equipment, net 

4,608


2,787

Intangible assets, net

8,802


11,018

Goodwill

20,519


21,128

 Total long-term assets 

37,133


36,026

Total assets

$         60,027


$         64,236

















                 Liabilities and Shareholders' Equity




    Current Liabilities:




Trade payables

$           1,668


$           1,017

Employees and payroll accruals 

3,959


3,239

Accrued expenses and other liabilities 

910


1,012

Earn-out consideration

2,926


3,588

Deferred revenues

5,773


5,032

 Total current liabilities 

15,236


13,888





Deferred revenues

503


524

Convertible notes

10,000


-

Deferred tax liability

1,130


1,355

Accrued severance pay 

598


930

Other liabilities

700


438

Total long-term liabilities

12,931


3,247





Shareholders' equity 

31,860


47,101

Total liabilities and shareholders' equity

$         60,027


$         64,236

 


CYREN LTD.









RECONCILIATION OF SELECTED GAAP MEASURES TO NON-GAAP MEASURES









(in thousands of U.S.dollars, except per share amounts)










Three months ended 


Twelve months ended 


December 31


December 31


2018


2017


2018


2017


Unaudited


Unaudited


Unaudited


Unaudited









GAAP operating loss

$  (5,366)


$  (5,020)


$(19,301)


$(13,762)

Stock-based compensation (1)

409


1,251


1,440


2,060

Amortization of intangible assets (2)

1,008


855


4,165


3,746

Capitalization of technology (6)

(204)


(1,012)


(2,090)


(3,728)

Non-GAAP operating loss

$  (4,153)


$  (3,926)


$(15,786)


$(11,684)









GAAP net loss

$  (5,572)


$  (7,242)


$(19,414)


$(15,648)

Stock-based compensation (1)

409


1,251


1,440


2,060

Amortization of intangible assets (2)

1,008


855


4,165


3,746

Adjustment to earn-out liabilities (3)

22


26


97


117

Amortization of deferred tax assets (4)

(58)


(63)


(246)


(249)

Gain from sale of investment in affiliate (5)

-


-


-


(450)

Capitalization of technology (6)

(208)


(1,057)


(2,094)


(3,822)

Accretion of discount on convertible note (7)

-


150


-


480

Change in fair value of embedded conversion feature on convertible note (8)

-


1,814


-


1,349

Non-GAAP net loss

$  (4,399)


$  (4,266)


$(16,052)


$(12,417)









GAAP loss per share (diluted)

$     (0.10)


$     (0.16)


$     (0.36)


$     (0.37)

Stock-based compensation (1)

0.01


0.03


0.02


0.05

Amortization of intangible assets (2)

0.02


0.02


0.08


0.11

Adjustment to earn-out liabilities (3)

0.00


0.00


0.00


0.00

Amortization of deferred tax assets (4)

0.00


(0.00)


0.00


(0.00)

Gain from sale of investment in affiliate (5)

0.00


0.00


0.00


(0.01)

Capitalization of technology (6)

0.00


(0.02)


(0.03)


(0.10)

Accretion of discount on convertible note (7)

0.00


0.00


0.00


0.00

Change in fair value of embedded conversion feature on convertible note (8)

0.00


0.04


0.00


0.03

Non-GAAP loss per share (diluted)

$     (0.07)


$     (0.09)


$     (0.29)


$     (0.29)









Numbers of shares used in computing non-GAAP loss per share (diluted)

54,023


46,018


53,634


40,922









(1) Stock-based compensation 








Cost of revenues 

$         50


$       131


$       174


$       207

Research and development 

110


277


407


505

Sales and marketing 

94


373


387


553

General and administrative 

155


470


472


795


$       409


$    1,251


$    1,440


$    2,060

(2) Amortization of intangible assets 








Cost of revenues 

$       861


$       687


$    3,553


$    3,071

Sales and marketing 

147


168


612


675


$    1,008


$       855


$    4,165


$    3,746

(3) Adjustment to earn-out liabilities and related expenses








Financial expenses, net 

$         22


$         26


$         97


$       117









(4) Amortization of deferred tax assets








Tax benefit (expense)

$        (58)


$        (63)


$      (246)


$      (249)









(5) Gain from sale of investment in affiliate








Other Income

$             -


$             -


$             -


$      (450)









(6) Capitalization of technology








Research and development

$      (204)


$  (1,012)


$  (2,090)


$  (3,728)

Financial expenses, net 

(4)


(45)


(4)


(94)


$      (208)


$  (1,057)


$  (2,094)


$  (3,822)









(7) Accretion of discount on convertible note








Financial expenses, net 

$             -


$       150


$             -


$       480









(8) Change in fair value of embedded conversion feature on convertible note








Financial expenses, net 

$             -


$    1,814


$             -


$    1,349

 


CYREN LTD.









 CONDENSED CONSOLIDATED CASH FLOW DATA









(in thousands of U.S. dollars)


























Three months ended 


Twelve months ended 


December 31


December 31


2018


2017


2018


2017

Cash flows from operating activities:

Unaudited


Unaudited


Unaudited


Audited









Net loss

$  (5,572)


$  (7,242)


$(19,414)


$(15,648)









Adjustments to reconcile loss to net cash used in operating activities:








Loss on disposal of property and equipment

1


1


15


2

Depreciation 

422


437


1,856


1,303

Stock-based compensation

409


1,251


1,440


2,060

Amortization of intangible assets

1,008


855


4,165


3,746

Amortization of deferred commissions

346


-


1,351


-

Interest and accretion of discount on convertible note

40


150


40


480

Change in fair value of embedded conversion feature on convertible note

-


1,814


-


1,349

Other income related to investment in affiliate

-


-


-


(450)

Other expenses related to the earn-out consideration

22


26


97


117

Deferred taxes

(30)


(29)


(182)


(175)


-


-


-


-

Changes in assets and liabilities:

-


-


-


-

Trade receivables

(304)


(291)


(596)


77

Prepaid expenses and other receivables

922


284


530


(362)

Deferred commissions

(510)


-


(2,307)


-

Change in long-term lease deposits

5


122


(105)


28

Trade payables

(42)


(45)


264


36

Employees and payroll accruals, accrued expenses and other liabilities

(162)


567


515


780

Deferred revenues

(2,319)


(1,085)


721


(841)

Accrued severance pay, net

(1)


(62)


(121)


4

Other long-term liabilities

203


302


274


302

Net cash used in operating activities

(5,562)


(2,945)


(11,457)


(7,192)









Cash flows from investing activities:
















Proceeds from sale of fixed assets

1


-


1


-

Proceeds from sale of investment in affiliate

-


-


-


450

Capitalization of technology, net of grants received

(140)


(1,046)


(1,984)


(3,567)

Purchase of property and equipment

(331)


(953)


(3,320)


(1,771)

Net cash used in investing activities

(470)


(1,999)


(5,303)


(4,888)









Cash flows from financing activities:
















Proceeds from convertible note

10,000


-


10,000


6,300

Proceeds from private capital raise

-


18,971


-


18,971

Payment of earnout liability

-


-


(604)


-

Proceeds from options exercised

117


18


1,393


93

Net cash provided by financing activities

10,117


18,989


10,789


25,364

Effect of exchange rate changes on cash, cash equivalents and restricted cash

(62)


21


(101)


98

Increase (decrease) in cash, cash equivalents and restricted cash

4,023


14,066


(6,072)


13,382

Cash, cash equivalents and restricted cash at the beginning of the period

14,133


10,162


24,228


10,846

Cash, cash equivalents and restricted cash at the end of the period

$ 18,156


$ 24,228


$  18,156


$  24,228









Reconciliation of cash, cash equivalents and restricted cash as shown in the consolidated statements of cash flow:
















Cash and cash equivalents

$ 17,571


$ 23,981


$  17,571


$  23,981

Restricted cash included in long-term restricted lease deposits

585


247


585


247









Total cash, cash equivalents and restricted cash

$ 18,156


$ 24,228


$  18,156


$  24,228


CYREN Logo. (PRNewsFoto/CYREN)

 

Cision

View original content to download multimedia:http://www.prnewswire.com/news-releases/cyren-reports-fourth-quarter-and-full-year-2018-financial-results-300794542.html